# # Summary Methods Section Schizophrenia Treatment Study section describes randomized clinical trial designed compare effectiveness two treatment strategies schizophrenia : typical atypical antipsychotics . * * Patients : * * * Included : diagnosed schizophrenia ( ICD-10 : F20.X ) , aged 18-65 , requiring treatment initiation change due insufficient response intolerability previous medication . * Excluded : known hypersensitivity study drugs , acute suicidality , involuntary treatment , significant somatic diseases . * Total : 149 patients recruited , 136 analyzed ( 13 dropped drug administration ) . * * Study Design : * * * Multicenter , double-blind , double-dummy , randomized trial 14 German psychiatric hospitals . * Patients randomized two groups : one receiving typical antipsychotic ( FGA ) receiving atypical antipsychotic ( SGA ) . * Treatment duration : 24 weeks . * Follow-up : offered 24 weeks treatment cessation . * * Medications : * * * FGAs : haloperidol ( 3-6mg ) flupentixol ( 6-12mg ) . * SGAs : aripiprazole ( 10-20mg ) , olanzapine ( 10-20mg ) , quetiapine ( 400-800mg ) . * Non-psychotropic medications allowed throughout study . * * Assessments : * * * Primary outcome : area curve ( AUC ) Short Form 36 Health Survey ( SF-36 ) Clinical Global Impression Severity ( CGI ) scores 24 weeks . * Secondary outcomes : Subjective Well-Being Neuroleptic Treatment Scale-Short Form ( SWN-K ) , Positive Negative Syndrome Scale ( PANSS ) , Mini-ICF-APP , cognitive tests , patient self-rated PSP . * Assessments conducted baseline , week 6 ( visit 4 ) , week 24 ( visit 6 ) . Additional assessments weeks 2 , 4 , 12 . * * Statistical Analysis : * * * Full analysis set ( FAS ) included randomized patients received least one dose medication . * Missing values imputed Last Observation Carried Forward ( LOCF ) linear interpolation . * Primary efficacy analysis focused AUC SF36 CGI scores . * Secondary analyses exploratory . * Statistical software : SASÂ® version 9.4 .